Literature DB >> 14594903

The human coronary collateral circulation.

Christian Seiler.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14594903      PMCID： PMC1767958          DOI： 10.1136/heart.89.11.1352

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  17 in total

1.  Pressure-derived fractional collateral blood flow: a primary determinant of left ventricular recovery after reperfused acute myocardial infarction.

Authors:  C W Lee; S W Park; G Y Cho; M K Hong; J J Kim; D H Kang; J K Song; H J Lee; S J Park
Journal:  J Am Coll Cardiol       Date:  2000-03-15       Impact factor: 24.094

2.  GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function.

Authors:  I R Buschmann; I E Hoefer; N van Royen; E Katzer; R Braun-Dulleaus; M Heil; S Kostin; C Bode; W Schaper
Journal:  Atherosclerosis       Date:  2001-12       Impact factor: 5.162

3.  Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment?

Authors:  M Billinger; M Fleisch; F R Eberli; A Garachemani; B Meier; C Seiler
Journal:  J Am Coll Cardiol       Date:  1999-03-15       Impact factor: 24.094

4.  Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease.

Authors:  T Pohl; C Seiler; M Billinger; E Herren; K Wustmann; H Mehta; S Windecker; F R Eberli; B Meier
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

5.  Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries?

Authors:  Kerstin Wustmann; Stephan Zbinden; Stephan Windecker; Bernhard Meier; Christian Seiler
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

6.  Physiologically assessed coronary collateral flow and adverse cardiac ischemic events: a follow-up study in 403 patients with coronary artery disease.

Authors:  Michael Billinger; Patrik Kloos; Franz R Eberli; Stephan Windecker; Bernhard Meier; Christian Seiler
Journal:  J Am Coll Cardiol       Date:  2002-11-06       Impact factor: 24.094

7.  Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study.

Authors:  C Seiler; T Pohl; K Wustmann; D Hutter; P A Nicolet; S Windecker; F R Eberli; B Meier
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

8.  Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial.

Authors:  Michael Simons; Brian H Annex; Roger J Laham; Neal Kleiman; Timothy Henry; Harold Dauerman; James E Udelson; Ernesto V Gervino; Marilyn Pike; M J Whitehouse; Thomas Moon; Nicolas A Chronos
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

9.  The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.

Authors:  Timothy D Henry; Brian H Annex; George R McKendall; Michael A Azrin; John J Lopez; Frank J Giordano; P K Shah; James T Willerson; Raymond L Benza; Daniel S Berman; C Michael Gibson; Alex Bajamonde; Amy Chen Rundle; Jennifer Fine; Edward R McCluskey
Journal:  Circulation       Date:  2003-03-18       Impact factor: 29.690

10.  Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects.

Authors:  K P Rentrop; M Cohen; H Blanke; R A Phillips
Journal:  J Am Coll Cardiol       Date:  1985-03       Impact factor: 24.094
View more
  31 in total

1.  A rare connection by newly formed conduit vessels between the left internal mammalian artery and radial artery bypass grafts after failure of grafts.

Authors:  Yoritaka Otsuka; Futoshi Yamanaka; Takafumi Yamane; Taichi Adachi; Eiji Tada; Nobuhito Yagi; Yu Kataoka; Yoichiro Kasahara; Hiroshi Nonogi
Journal:  Heart Vessels       Date:  2010-11-26       Impact factor: 2.037

2.  Collaterals: how important are they?

Authors:  Gerald S Werner
Journal:  Heart       Date:  2007-07       Impact factor: 5.994

Review 3.  Regulating myocardial blood flow in health and disease.

Authors:  Henry Gewirtz
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

4.  Endocan: a novel biomarker associated with well-developed coronary collateral circulation in patients with stable angina and chronic total occlusion.

Authors:  Samim Emet; Ali Elitok; Imran Onur; Mehmet Kocaaga; Ahmet Kaya Bilge; Huseyin Oflaz; Berrin Umman; Aytac Oncul; Zehra Bugra; Kamil Adalet; Fehmi Mercanoglu
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

5.  MMPs 2 and 9 are essential for coronary collateral growth and are prominently regulated by p38 MAPK.

Authors:  Tracy Dodd; Rashmi Jadhav; Luke Wiggins; James Stewart; Erika Smith; James C Russell; Petra Rocic
Journal:  J Mol Cell Cardiol       Date:  2011-08-22       Impact factor: 5.000

Review 6.  Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.

Authors:  Vasken Dilsizian; Henry Gewirtz; Nicholas Paivanas; Anastasia N Kitsiou; Fadi G Hage; Nathan E Crone; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2015-05-15       Impact factor: 5.952

Review 7.  Effects of exercise training on coronary collateralization and control of collateral resistance.

Authors:  Cristine L Heaps; Janet L Parker
Journal:  J Appl Physiol (1985)       Date:  2011-05-12

8.  Poor coronary collateral vessel development in patients with mild to moderate renal insufficiency.

Authors:  Shuang-lun Xie; Hai-yan Li; Bing-qing Deng; Nian-sang Luo; Deng-feng Geng; Jing-feng Wang; Ru-qiong Nie
Journal:  Clin Res Cardiol       Date:  2010-09-25       Impact factor: 5.460

9.  Stem/Progenitor cells, atherosclerosis and cardiovascular regeneration.

Authors:  Olena Dotsenko
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

10.  Impaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatin.

Authors:  Tracy Dodd; Luke Wiggins; Rebecca Hutcheson; Erika Smith; Alla Musiyenko; Brenda Hysell; James C Russell; Petra Rocic
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-18       Impact factor: 8.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.